» Articles » PMID: 27959614

Diabetes and Cause-Specific Mortality in Mexico City

Abstract

Background: Most large, prospective studies of the effects of diabetes on mortality have focused on high-income countries where patients have access to reasonably good medical care and can receive treatments to establish and maintain good glycemic control. In those countries, diabetes less than doubles the rate of death from any cause. Few large, prospective studies have been conducted in middle-income countries where obesity and diabetes have become common and glycemic control may be poor.

Methods: From 1998 through 2004, we recruited approximately 50,000 men and 100,000 women 35 years of age or older into a prospective study in Mexico City, Mexico. We recorded the presence or absence of previously diagnosed diabetes, obtained and stored blood samples, and tracked 12-year disease-specific deaths through January 1, 2014. We accepted diabetes as the underlying cause of death only for deaths that were due to acute diabetic crises. We estimated rate ratios for death among participants who had diabetes at recruitment versus those who did not have diabetes at recruitment; data from participants who had chronic diseases other than diabetes were excluded from the main analysis.

Results: At the time of recruitment, obesity was common and the prevalence of diabetes rose steeply with age (3% at 35 to 39 years of age and >20% by 60 years of age). Participants who had diabetes had poor glycemic control (mean [±SD] glycated hemoglobin level, 9.0±2.4%), and the rates of use of other vasoprotective medications were low (e.g., 30% of participants with diabetes were receiving antihypertensive medication at recruitment and 1% were receiving lipid-lowering medication). Previously diagnosed diabetes was associated with rate ratios for death from any cause of 5.4 (95% confidence interval [CI], 5.0 to 6.0) at 35 to 59 years of age, 3.1 (95% CI, 2.9 to 3.3) at 60 to 74 years of age, and 1.9 (95% CI, 1.8 to 2.1) at 75 to 84 years of age. Between 35 and 74 years of age, the excess mortality associated with previously diagnosed diabetes accounted for one third of all deaths; the largest absolute excess risks of death were from renal disease (rate ratio, 20.1; 95% CI, 17.2 to 23.4), cardiac disease (rate ratio, 3.7; 95% CI, 3.2 to 4.2), infection (rate ratio, 4.7; 95% CI, 4.0 to 5.5), acute diabetic crises (8% of all deaths among participants who had previously diagnosed diabetes), and other vascular disease (mainly stroke). Little association was observed between diabetes and mortality from cirrhosis, cancer, or chronic obstructive pulmonary disease.

Conclusions: In this study in Mexico, a middle-income country with high levels of obesity, diabetes was common, glycemic control was poor, and diabetes was associated with a far worse prognosis than that seen in high-income countries; it accounted for at least one third of all deaths between 35 and 74 years of age. (Funded by the Wellcome Trust and others.).

Citing Articles

Multiple long-term conditions as the next transition in the global diabetes epidemic.

Gregg E, Holman N, Sophiea M, Misra S, Pearson-Stuttard J, Valabhji J Commun Med (Lond). 2025; 5(1):42.

PMID: 39953177 PMC: 11828996. DOI: 10.1038/s43856-025-00742-9.


Cognitive impairment at older ages among 8000 men and women living in Mexico City: a cross-sectional analyses of a prospective study.

Gonzalez-Carballo C, Kuri-Morales P, Chiquete E, Rojas-Russell M, Santacruz-Benitez R, Ramirez-Reyes R BMC Public Health. 2024; 24(1):3620.

PMID: 39741255 PMC: 11687187. DOI: 10.1186/s12889-024-21093-5.


Halving premature death and improving quality of life at all ages: cross-country analyses of past trends and future directions.

Norheim O, Chang A, Bolongaita S, Barraza-Llorens M, Fawole A, Gebremedhin L Lancet. 2024; 404(10470):2437-2446.

PMID: 39581203 PMC: 11667436. DOI: 10.1016/S0140-6736(24)02417-6.


Alcohol and mortality in Mexico: prospective study of 150 000 adults.

Trichia E, Alegre-Diaz J, Aguilar-Ramirez D, Ramirez-Reyes R, Garcilazo-Avila A, Gonzalez-Carballo C Lancet Public Health. 2024; 9(11):e907-e915.

PMID: 39486906 PMC: 7616839. DOI: 10.1016/S2468-2667(24)00228-7.


Smoking, all-cause, and cause-specific mortality in individuals with diabetes in Mexico: an analysis of the Mexico city prospective study.

Ramirez-Garcia D, Fermin-Martinez C, Sanchez-Castro P, Nunez-Luna A, Basile-Alvarez M, Fernandez-Chirino L BMC Public Health. 2024; 24(1):2383.

PMID: 39223469 PMC: 11370065. DOI: 10.1186/s12889-024-19536-0.


References
1.
Roglic G, Unwin N . Mortality attributable to diabetes: estimates for the year 2010. Diabetes Res Clin Pract. 2009; 87(1):15-9. DOI: 10.1016/j.diabres.2009.10.006. View

2.
Hoerger T, Segel J, Gregg E, Saaddine J . Is glycemic control improving in U.S. adults?. Diabetes Care. 2007; 31(1):81-6. DOI: 10.2337/dc07-1572. View

3.
Sarwar N, Gao P, Kondapally Seshasai S, Gobin R, Kaptoge S, Di Angelantonio E . Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010; 375(9733):2215-22. PMC: 2904878. DOI: 10.1016/S0140-6736(10)60484-9. View

4.
Danaei G, Finucane M, Lu Y, Singh G, Cowan M, Paciorek C . National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011; 378(9785):31-40. DOI: 10.1016/S0140-6736(11)60679-X. View

5.
Youngman L, Clark S, Manley S, Peto R, Collins R . Reliable measurement of glycated hemoglobin in frozen blood samples: implications for epidemiologic studies. Clin Chem. 2002; 48(9):1627-9. View